Panton-Valentine leukocidin in pediatric community-acquired Staphylococcus aureus infections. 2009

Jesse Papenburg, and Patricia Fontela, and Lélia Raynal, and Louise Jetté, and Johanne Ismail, and Sadjia Bekal, and Ibrahim Al-Zahrani, and Caroline Quach
Department of Pediatrics, Montreal Children's Hospital, McGill University Health Centre, Montreal, Quebec, Canada.

OBJECTIVE Panton-Valentine Leukocidin (PVL) is an exotoxin produced by strains of Staphylococcus aureus (SA). Its importance as a virulence factor is controversial. We aim to further characterize the role of PVL in pediatric community-acquired SA infections. METHODS In a cohort study conducted from July to November 2006, we prospectively collected all strains of SA isolated at the Montreal Children's Hospital causing community-acquired infections in children aged 18 years or younger. The strains were analyzed for the presence of the PVL encoding genes by PCR and were phage typed. Strains resistant to methicillin or pvl+ were analyzed by pulsed-field gel electrophoresis. A medical chart review blinded to patient pvl status was performed to retrieve demographic and clinical data. Data were analyzed by logistic regression. RESULTS We identified 74 pediatric community-acquired SA infections. Nineteen strains (25.7%) were positive for the pvl genes. Four isolates (5.4%) were resistant to methicillin and three of these were pvl+. No predominant clone was identified by phage typing or pulsed field gel electrophoresis. Pvl+ and pvl- infections were statistically similar for patient age, hospital admission, length of hospital stay, invasive disease, intravenous antibiotics and outcomes. Pvl+ strains were more likely to cause abscesses (OR 20.79; 95% CI 4.93 - 87.58), less likely to cause superficial skin infections (OR 0.18; 95% CI 0.05 - 0.64) and less likely to be resistant to erythromycin (OR 0.048; 95% CI 0.004 - 0.52). CONCLUSIONS In a clonally heterogeneous population of pediatric community-acquired SA infections, pvl+ strains were associated with abscess formation and erythromycin susceptibility, but not invasive disease.

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D007956 Leukocidins Pore forming proteins originally discovered for toxic activity to LEUKOCYTES. They are EXOTOXINS produced by some pathogenic STAPHYLOCOCCUS and STREPTOCOCCUS that destroy leukocytes by lysis of the cytoplasmic granules and are partially responsible for the pathogenicity of the organisms. Leucocidin,Leukocidin,Leukocidin Proteins,Proteins, Leukocidin
D008297 Male Males
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D005098 Exotoxins Toxins produced, especially by bacterial or fungal cells, and released into the culture medium or environment. Exotoxin
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D001427 Bacterial Toxins Toxic substances formed in or elaborated by bacteria; they are usually proteins with high molecular weight and antigenicity; some are used as antibiotics and some to skin test for the presence of or susceptibility to certain diseases. Bacterial Toxin,Toxins, Bacterial,Toxin, Bacterial

Related Publications

Jesse Papenburg, and Patricia Fontela, and Lélia Raynal, and Louise Jetté, and Johanne Ismail, and Sadjia Bekal, and Ibrahim Al-Zahrani, and Caroline Quach
November 2014, Biotechnology, biotechnological equipment,
Jesse Papenburg, and Patricia Fontela, and Lélia Raynal, and Louise Jetté, and Johanne Ismail, and Sadjia Bekal, and Ibrahim Al-Zahrani, and Caroline Quach
May 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America,
Jesse Papenburg, and Patricia Fontela, and Lélia Raynal, and Louise Jetté, and Johanne Ismail, and Sadjia Bekal, and Ibrahim Al-Zahrani, and Caroline Quach
October 2019, The Pediatric infectious disease journal,
Jesse Papenburg, and Patricia Fontela, and Lélia Raynal, and Louise Jetté, and Johanne Ismail, and Sadjia Bekal, and Ibrahim Al-Zahrani, and Caroline Quach
January 2007, Laboratory investigation; a journal of technical methods and pathology,
Jesse Papenburg, and Patricia Fontela, and Lélia Raynal, and Louise Jetté, and Johanne Ismail, and Sadjia Bekal, and Ibrahim Al-Zahrani, and Caroline Quach
January 2009, Clinical and vaccine immunology : CVI,
Jesse Papenburg, and Patricia Fontela, and Lélia Raynal, and Louise Jetté, and Johanne Ismail, and Sadjia Bekal, and Ibrahim Al-Zahrani, and Caroline Quach
November 2006, Emerging infectious diseases,
Jesse Papenburg, and Patricia Fontela, and Lélia Raynal, and Louise Jetté, and Johanne Ismail, and Sadjia Bekal, and Ibrahim Al-Zahrani, and Caroline Quach
July 2012, Archives de pediatrie : organe officiel de la Societe francaise de pediatrie,
Jesse Papenburg, and Patricia Fontela, and Lélia Raynal, and Louise Jetté, and Johanne Ismail, and Sadjia Bekal, and Ibrahim Al-Zahrani, and Caroline Quach
January 2018, Journal of infection and public health,
Jesse Papenburg, and Patricia Fontela, and Lélia Raynal, and Louise Jetté, and Johanne Ismail, and Sadjia Bekal, and Ibrahim Al-Zahrani, and Caroline Quach
August 2003, Emerging infectious diseases,
Jesse Papenburg, and Patricia Fontela, and Lélia Raynal, and Louise Jetté, and Johanne Ismail, and Sadjia Bekal, and Ibrahim Al-Zahrani, and Caroline Quach
April 2009, Anales de pediatria (Barcelona, Spain : 2003),
Copied contents to your clipboard!